Sign In
Buy AMRX
$18.09
+0.170 (+0.95%)
At Close: Jul 27, 2026
Amneal running out of hydroxychloroquine raw material, co-CEOs say
05:02pm, Sunday, 12'th Apr 2020
Amneal Pharmaceuticals (NYSE:AMRX) may soon run out of the raw ingredients to make hydroxychloroquine because Finland is keeping the drug for domestic use, the company's co-CEOs tell Reuters.Amneal ha
Did You Manage To Avoid Amneal Pharmaceuticals’s (NYSE:AMRX) Devastating 75% Share Price Drop?
12:22pm, Saturday, 11'th Apr 2020
Amneal Pharmaceuticals, Inc. (NYSE:AMRX) shareholders should be happy to see the share price up 16% in the last month...
EXCLUSIVE-Amneal running out of hydroxychloroquine raw material due to Finnish restrictions
03:25pm, Friday, 10'th Apr 2020
Amneal Pharmaceuticals could soon run out of the raw ingredients to make more of the antimalarial drug hydroxychloroquine that has been touted as a potential treatment for COVID-19 because Finland is
Exclusive: Amneal running out of hydroxychloroquine raw material due to Finnish restrictions
03:18pm, Friday, 10'th Apr 2020
Amneal Pharmaceuticals could soon run out of the raw ingredients to make more of the antimalarial drug hydroxychloroquine that has been touted as a potential treatment for COVID-19 because Finland is
EXCLUSIVE-Amneal running out of hydroxychloroquine raw material due to Finnish restrictions
03:11pm, Friday, 10'th Apr 2020
Amneal Pharmaceuticals could soon run out of the raw ingredients to make more of the antimalarial drug hydroxychloroquine that has been touted as a potential treatment for COVID-19 because Finland is
Amneal Pharmaceuticals (NYSE:AMRX) Shares Down 7.3%
10:12am, Wednesday, 08'th Apr 2020
Shares of Amneal Pharmaceuticals Inc (NYSE:AMRX) dropped 7.3% during trading on Tuesday . The company traded as low as $2.86 and last traded at $2.91, approximately 2,324,233 shares traded hands durin
Amneal Pharmaceuticals Inc (NYSE:AMRX) Given Consensus Recommendation of "Hold" by Brokerages
05:30am, Wednesday, 08'th Apr 2020
Amneal Pharmaceuticals Inc (NYSE:AMRX) has been assigned an average recommendation of “Hold” from the fourteen analysts that are covering the stock, MarketBeat Ratings reports. Two investment anal
Trump and his allies have a stake in promoting hydroxychloroquine
10:31pm, Tuesday, 07'th Apr 2020
Several pharmaceutical companies stand to profit from the drug's promotion, including shareholders and senior executives with connections to the president.
Barron's on MarketWatch: Could COVID-19 bring generic-drug making back to U.S.?
01:49pm, Tuesday, 07'th Apr 2020
SVB Leerink analyst Ami Fadia says the pandemic could bring some relief to beaten-down generic-drug companies.
Covid-19 Could Bring Generic Drug Manufacturing Back to the U.S., Analyst Writes
01:46pm, Tuesday, 07'th Apr 2020
SVB Leerink analyst Ami Fadia says the pandemic could bring some relief to beaten-down generic-drug companies.
Trump’s personal stake in the malaria-drug maker Sanofi could be as small as $99
01:45pm, Tuesday, 07'th Apr 2020
The New York Times, in a major article, says Trump has a “small personal stake” in Sanofi, the French drugmaker that produces the drug. Here’s how small.
Amneal Pharmaceuticals (NYSE:AMRX) Trading 9.4% Higher
06:14am, Tuesday, 07'th Apr 2020
Amneal Pharmaceuticals Inc (NYSE:AMRX) traded up 9.4% on Monday . The company traded as high as $3.16 and last traded at $3.14, 1,525,343 shares traded hands during trading. A decline of 19% from the
Malaria drugs in high demand amid COVID-19
02:40pm, Sunday, 05'th Apr 2020
States across the U.S. are instituting measures to prevent hoarding of malaria drugs hydroxychloroquine and chloroquine in an effort to maintain supply amid acute demand from pharmacies and COVID-19 p
Great West Life Assurance Co. Can Purchases New Holdings in Amneal Pharmaceuticals Inc (NYSE:AMRX)
11:42am, Friday, 03'rd Apr 2020
Great West Life Assurance Co. Can purchased a new stake in shares of Amneal Pharmaceuticals Inc (NYSE:AMRX) in the 4th quarter, Holdings Channel reports. The fund purchased 7,150 shares of the company
Amneal Pharmaceuticals Inc (NYSE:AMRX) Stock Position Raised by Amalgamated Bank
08:40am, Friday, 03'rd Apr 2020
Amalgamated Bank lifted its position in Amneal Pharmaceuticals Inc (NYSE:AMRX) by 19.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange
